In vitro study of 2,3-dehydrosilybin and its galloyl esters as potential inhibitors of angiogenesis

Pharmazie

Volumn 71, Issue 8, 2016, Pages 478-484

  Pivodova V ^a,b   Zahler, S ^b   Karas, D ^a   Valentova K ^c   Ulrichova, J ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b PALACKÝ UNIVERSITY   (Czech Republic)

^c INSTITUTE OF MICROBIOLOGY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DEHYDROSILYBIN; 20 O GALLOYL 2,3 DEHYDROSILYBIN; 23 O GALLOYL 2,3 DEHYDROSILYBIN; 3 O GALLOYL 2,3 DEHYDROSILYBIN; 7 O GALLOYL 2,3 DEHYDROSILYBIN; ANGIOGENESIS INHIBITOR; FLAVONOID; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SILIBININ; UNCLASSIFIED DRUG; ESTER; GALLIC ACID; ONCOPROTEIN; SILYMARIN;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ARTICLE; CAPILLARY ENDOTHELIAL CELL; CELL COUNT; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; CELL CYCLE; DRUG EFFECTS; ENDOTHELIUM CELL; MAPK SIGNALING; MICROTUBULE; NEOVASCULARIZATION (PATHOLOGY); STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANGIOGENESIS INHIBITORS; CELL CYCLE; CELL PROLIFERATION; ENDOTHELIAL CELLS; ESTERS; GALLIC ACID; HUMANS; MAP KINASE SIGNALING SYSTEM; MICROTUBULES; NEOVASCULARIZATION, PATHOLOGIC; ONCOGENE PROTEIN V-AKT; PHOSPHATIDYLINOSITOL 3-KINASES; SILYMARIN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84989864018     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2016.6579     Document Type: Article

References (44)

1. Agarwal R (2000) Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents. Biochem Pharmacol 60: 1051-1059.
2. Agarwal C, Singh RP, Dhanalakshmi S, Tyagi AK, Tecklenburg M, Sclafani RA, Agarwal R (2003) Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells. Oncogene 22: 8271-8282.
3. Agarwal C, Wadhwa R, Deep G, Biedermann D, Gazak R, Kren V, Agarwal R (2013) Anti-cancer efficacy of silybin derivatives-a structure-activity relationship. PloS one 8: e60074.
4. Alon T, Hemo I, Itin A, Peer J, Stone J, Keshet E (1995) Vascular endothelial growthfactor acts as a survival factor for newly formed retinal-vessels and has implications for retinopathy of prematurity. Nat Med 1: 1024-1028.
5. Beraud C, Henzel WJ, Baeuerle PA (1999) Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-kappaB activation. Proc Natl Acad Sci USA 96: 429-434.
6. Dai J, Peng L, Fan K, Wang H, Wei R, Ji G, Cai J, Lu B, Li B, Zhang D, Kang Y, Tan M, Qian W, Guo Y (2009) Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells. Oncogene 28: 3412-3422.
7. Davis-Searles PR, Nakanishi Y, Kim NC, Graf TN, Oberlies NH, Wani MC, Wall ME, Agarwal R, Kroll DJ (2005) Milk thistle and prostate cancer: differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells. Cancer Res 65: 4448-4457.
8. Deep G, Agarwal R (2013) Targeting tumor microenvironment with silibinin: promise and potential for a translational cancer chemopreventive strategy. Curr Cancer Drug Targets 13: 486-499.
9. Deep G, Gangar SC, Rajamanickam S, Raina K, Gu M, Agarwal C, Oberlies NH, Agarwal R (2012) Angiopreventive efficacy of pure flavonolignans from milk thistle extract against prostate cancer: targeting VEGF-VEGFR signaling. PloS one 7: e34630.
10. Folkman J, Watson K, Ingber D, Hanahan D (1989) Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339: 58-61.
11. Gabrielova E, Jaburek M, Gazak R, Vostalova J, Jezek J, Kren V, Modriansky M (2010) Dehydrosilybin attenuates the production of ROS in rat cardiomyocyte mitochondria with an uncoupler-like mechanism. J Bioenerg Biomembr 42: 499-509.
12. Gazak R, Svobodova A, Psotova J, Sedmera P, Prikrylova V, Walterova D, Kren V (2004) Oxidised derivatives of silybin and their antiradical and antioxidant activity. Bioorg Med Chem 12: 5677-5687.
13. Gazak R, Valentova K, Fuksova K, Marhol P, Kuzma M, Medina MA, Oborna I, Ulrichova J, Kren V (2011) Synthesis and antiangiogenic activity of new silybin galloyl esters. J Med Chem 54: 7397-7407.
14. Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364.
15. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
16. Huber A, Thongphasuk P, Erben G, Lehmann WD, Tuma S, Stremmel W, Chamulitrat W (2008) Significantly greater antioxidant anticancer activities of 2, 3-dehydrosilybin than silybin. Biochimi Biophys Acta 1780: 837-847.
17. Chakrabarti M, Ray SK (2015) Anti-tumor activities of luteolin and silibinin in glioblastoma cells: overexpression of miR-7-1-3p augmented luteolin and silibinin to inhibit autophagy and induce apoptosis in glioblastoma in vivo. Apoptosis 21: 312-328.
18. Cho BO, Ryu HW, So Y, Jin CH, Baek JY, Park KH, Byun EH, Jeong IY (2013a) Hepatoprotective effect of 2, 3-dehydrosilybin on carbon tetrachloride-induced liver injury in rats. Food Chem 138: 107-115.
19. Cho HJ, Suh DS, Moon SH, Song YJ, Yoon MS, Park DY, Choi KU, Kim YK, Kim KH (2013b) Silibinin inhibits tumor growth through downregulation of extracellular signal-regulated kinase and Akt in vitro and in vivo in human ovarian cancer cells. J Agric Food Chem 61: 4089-4096.
20. Javerzat S, Auguste P, Bikfalvi A (2002) The role of fibroblast growth factors in vascular development. Trends Mol Med 8: 483-489.
21. Jiang C, Agarwal R, Lu J (2000) Anti-angiogenic potential of a cancer chemopreventive flavonoid antioxidant, silymarin: inhibition of key attributes of vascular endothelial cells and angiogenic cytokine secretion by cancer epithelial cells. Biochem Biophys Res Commun 276: 371-378.
22. Jiang Q, Liu Y, Duan D, Gou M, Wang H, Wang J, Li Q, Xiao R (2016) Anti-angiogenic activities of CRBGP from buccal glands of lampreys (Lampetra japonica). Biochimie 123: 7-19.
23. Kane LP, Shapiro VS, Stokoe D, Weiss A (1999) Induction of NF-kappaB by the Akt/ PKB kinase. Curr Biol 9: 601-604.
24. Karas D, Gazak R, Valentova K, Chambers CS, Pivodova V, Biedermann D, Krenkova A, Oborna I, Kuzma M, Cvacka J, Ulrichova J, Kren V (2016) Dehydrosilybin, its galloyl and methyl derivatives: Effect on human umbilical vein endothelial cells. J Nat Prod: 79: 812-820.
25. L'Hote CGM, Knowles MA (2005) Cell responses to FGFR3 signalling: growth, differentiation and apoptosis. Exp Cell Res 304: 417-431.
26. Lu K, Basu S (2015) The natural compound chebulagic acid inhibits vascular endothelial growth factor A mediated regulation of endothelial cell functions. Sci Rep 5: 9642.
27. Nor JE, Polverini PJ (1999) Role of endothelial cell survival and death signals in angiogenesis. Angiogenesis 3: 101-116.
28. Pugazhenthi S, Nesterova A, Sable C, Heidenreich KA, Boxer LM, Heasley LE, Reusch JEB (2000) Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. J Biol Chem 275: 10761-10766.
29. Rarova L, Zahler S, Liebl J, Krystof V, Sedlak D, Bartunek P, Kohout L, Strnad M (2012) Brassinosteroids inhibit in vitro angiogenesis in human endothelial cells. Steroids 77: 1502-1509.
30. Shimo T, Nakanishi T, Nishida T, Asano M, Kanyama M, Kuboki T, Tamatani T, Tezuka K, Takemura M, Matsumura T, Takigawa M (1999) Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo. J Biochem 126: 137-145.
31. Shiojima I, Walsh K (2002) Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res 90: 1243-1250.
32. Singh RP, Dhanalakshmi S, Agarwal C, Agarwal R (2005) Silibinin strongly inhibits growth and survival of human endothelial cells via cell cycle arrest and downregulation of survivin, Akt and NF-kappaB: implications for angioprevention and antiangiogenic therapy. Oncogene 24: 1188-1202.
33. Singh RP, Raina K, Sharma G, Agarwal R (2008a) Silibinin inhibits established prostate tumor growth, progression, invasion, and metastasis and suppresses tumor angiogenesis and epithelial-mesenchymal transition in transgenic adenocarcinoma of the mouse prostate model mice. Clin Cancer Res 14: 7773-7780.
34. Singh RP, Tyagi A, Sharma G, Mohan S, Agarwal R (2008b) Oral silibinin inhibits in vivo human bladder tumor xenograft growth involving down-regulation of survivin. Clin Cancer Res 14: 300-308.
35. Sousa M, Machado V, Figueira ME, Sepodes B, Barata P, Ribeiro L, Soares R (2015) Red raspberry phenols inhibit angiogenesis: a morphological and subcellular analysis upon human endothelial cells. J Cell Biochem doi 10.1002/jcb.25452.
36. Svobodova A, Zdarilova A, Walterova D, Vostalova J (2007) Flavonolignans from Silybum marianum moderate UVA-induced oxidative damage to HaCaT keratinocytes. J Dermatol Sci 48: 213-224.
37. Thongphasuk P, Stremmel W, Chamulitrat W (2008) Potent direct or TNF-alphapromoted anticancer effects of 2, 3-dehydrosilybin: comparison study with silybin. Chemotherapy 54: 23-30.
38. Tilley C, Deep G, Agarwal C, Wempe MF, Biedermann D, Valentova K, Kren V, Agarwal R (2016) Silibinin and its 2, 3-dehydro-derivative inhibit basal cell carcinoma growth via suppression of mitogenic signaling and transcription factors activation. Mol Carcinog 55: 3-14.
39. Tyagi A, Bhatia N, Condon MS, Bosland MC, Agarwal C, Agarwal R (2002) Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells. Prostate 53: 211-217.
40. Wang S, Cai R, Ma J, Liu T, Ke X, Lu H, Fu J (2015) The natural compound codonolactone impairs tumor induced angiogenesis by downregulating BMP signaling in endothelial cells. Phytomedicine 22: 1017-1026.
41. Weitensteiner SB, Liebl J, Krystof V, Havlicek L, Gucky T, Strnad M, Furst R, Vollmar AM, Zahler S (2013) Trisubstituted pyrazolopyrimidines as novel angiogenesis inhibitors. PloS one 8: e54607.
42. Wu LW, Mayo LD, Dunbar JD, Kessler KM, Baerwald MR, Jaffe EA, Wang D, Warren RS, Donner DB (2000) Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation. J Biol Chem 275: 5096-5103.
43. Yi L, Li F, Yong Y, Jianting D, Liting Z, Xuansheng H, Fei L, Jiewen L (2014) Upregulation of sestrin-2 expression protects against endothelial toxicity of angiotensin II. Cell Biol Toxicol 30: 147-156.
44. Zhan T, Digel M, Kuch EM, Stremmel W, Fullekrug J (2011) Silybin and dehydrosilybin decrease glucose uptake by inhibiting GLUT proteins. J Cell Biochem 112: 849-859.